Supernus Pharmaceuticals Inc (SUPN)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 81,666 | -5,269 | 46,124 | 86,029 | 173,698 |
| Revenue | US$ in thousands | 661,817 | 607,521 | 673,056 | 560,079 | 500,962 |
| Operating profit margin | 12.34% | -0.87% | 6.85% | 15.36% | 34.67% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $81,666K ÷ $661,817K
= 12.34%
Supernus Pharmaceuticals Inc's operating profit margin has seen fluctuations over the past five years. Starting at a strong level of 34.67% at the end of December 2020, it declined significantly to 15.36% by the end of December 2021. The downward trend continued, with the operating margin further decreasing to 6.85% by the end of December 2022 and turning negative at -0.87% by the end of December 2023.
However, the company showed signs of improvement as it managed to rebound to a positive level of 12.34% by the end of December 2024. The overall trend suggests that Supernus Pharmaceuticals Inc has experienced challenges in maintaining its operating profit margin, but the recent improvement indicates a potential recovery in profitability. Further analysis of the company's operational efficiency and cost management strategies may provide insights into these fluctuations.
Peer comparison
Dec 31, 2024